Authors: Mohammad K Parvez (King Saud University College of Pharmacy, Riyadh, Saudi Arabia)
In this behind the scenes interview with Mohammad K Parvez on the recently published paper: ‘COVID-19 and coronaviral hepatitis: evidence of collateral damage‘ Parvez draws upon expertize as a virologist to examine the effects of COVID-19 on the gastrointestinal system. The full Commentary article is featured in a Special Focus Issue published with Future Virology.
What inspired you to write this piece?
I have been working on viral hepatitis (hepatitis B and E) and liver diseases for over two decades. As a virologist, I knew the gastrointestinal (GI) manifestations, including liver dysfunction, by human coronaviruses. The recent emergence of SARS-CoV-2 and associated digestive symptoms, notably liver inflammation in a proportion of COVID-19 patients, attracted my interest to write this article on ‘coronaviral’ hepatitis.
The opinions expressed in this interview are those of the interviewee and do not necessarily reflect the views of Infectious Diseases Hub or Future Science Group.